Paul Secrist

Paul Secrist

Company: Cyteir Therapeutics

Job title: Chief Scientific Officer

Seminars:

Targeting RAD51-Mediated Homologous Recombination as a Novel Therapeutic Approach to Treating Cancer Patients 12:15 pm

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.